The current GRFS market cap is 2.8B. The company's latest EPS is EUR 0.1392 and P/E is 60.78.
Quarter End | Dec 2020 | Mar 2021 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 1.35B | 1.18B | 1.56B | 1.66B | 1.6B |
Operating Income | -477.45M | 247.43M | 50.57M | -171.06M | -462.64M |
Net Income | 132.86M | 129.94M | -108.27M | 52.05M | 59.54M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 5.15B | 5.39B | 5B | 6.06B | 6.59B |
Operating Income | 1.09B | 1.06B | 628.25M | 804.2M | 798.48M |
Net Income | 625.15M | 618.55M | 182.8M | 208.28M | 59.32M |
Quarter End | Dec 2020 | Mar 2021 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 15.27B | 16.14B | 21.35B | 21.43B | 22.06B |
Total Liabilities | 8.55B | 8.94B | 13.18B | 13.21B | 13.5B |
Total Equity | 6.72B | 7.2B | 8.18B | 8.22B | 8.57B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 15.54B | 15.27B | 19.23B | 21.53B | 21.44B |
Total Liabilities | 8.7B | 8.55B | 11.09B | 13.08B | 13.47B |
Total Equity | 6.85B | 6.72B | 8.15B | 8.46B | 7.97B |
Quarter End | Dec 2020 | Mar 2021 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | 1.11B | 177.67M | -61.46M | -103.74M | 51.9M |
Investing | -858.12M | -566.96M | -83.04M | -132.87M | -255.76M |
Financing | -354.4M | 168.86M | 29.01M | 218.95M | 139.57M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | 568.93M | 1.11B | 596.98M | -10.87M | 208.28M |
Investing | -548.79M | -858.12M | -29.39M | -1.98B | -397.64M |
Financing | -332.36M | -354.4M | 1.47B | -173.49M | 186.05M |
Market Cap | 2.8B |
Price to Earnings Ratio | 60.78 |
Price to Sales Ratio | 0.55 |
Price to Cash Ratio | 6.81 |
Price to Book Ratio | 0.45 |
Dividend Yield | - |
Shares Outstanding | 426.13M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.01 (0.15%) |
Company Name | Grifols SA |
Address |
calle jesus i maria, 6 barcelona, catalonia 08174 |
Website | https://www.grifols.com |
Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.